Ocular Therapeutix, Inc. (OCUL)
NASDAQ: OCUL · Real-Time Price · USD
10.04
-0.06 (-0.59%)
At close: Aug 14, 2026, 4:00 PM EDT
10.05
+0.01 (0.10%)
After-hours: Aug 14, 2026, 7:34 PM EDT
Ocular Therapeutix Market Cap
Ocular Therapeutix has a market cap or net worth of $2.2 billion as of August 14, 2026. Its market cap has increased by 1.38% in one year.
Market Cap
2.20B
Enterprise Value
1.69B
1-Year Change
1.38%
Ranking
Category
Stock Price
$10.04
ChartMarket Cap Chart
Since July 25, 2014, Ocular Therapeutix's market cap has increased from $270.50M to $2.20B, an increase of 715.14%. That is a compound annual growth rate of 19.00%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 2.20B | -14.75% |
| Dec 31, 2025 | 2.59B | 92.64% |
| Dec 31, 2024 | 1.34B | 279.05% |
| Dec 29, 2023 | 354.20M | 63.68% |
| Dec 30, 2022 | 216.40M | -59.48% |
| Dec 31, 2021 | 534.00M | -63.87% |
| Dec 31, 2020 | 1.48B | 678.20% |
| Dec 31, 2019 | 189.90M | 16.08% |
| Dec 31, 2018 | 163.60M | 24.89% |
| Dec 29, 2017 | 131.00M | -37.08% |
| Dec 30, 2016 | 208.20M | -10.18% |
| Dec 31, 2015 | 231.80M | -53.78% |
| Dec 31, 2014 | 501.50M | 85.40% |
| Jul 25, 2014 | 270.50M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Kailera Therapeutics | 2.33B |
| Precigen | 2.32B |
| Mineralys Therapeutics | 2.31B |
| Vericel | 2.28B |
| Rapport Therapeutics | 2.27B |
| Palvella Therapeutics | 2.26B |
| Biohaven | 2.24B |
| Harmony Biosciences Holdings | 2.24B |